Navigation Links
FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
Date:6/30/2011

READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ -- Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Lazanda® (fentanyl) nasal spray for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.  Lazanda marks the first FDA product approval for Archimedes Pharma. Lazanda is marketed as PecFent® (fentanyl pectin nasal spray) in Europe, where it is presently available in five countries.

(Logo: http://photos.prnewswire.com/prnh/20110630/NY29236LOGO)

"Lazanda is an important new option for patients with cancer who experience excruciating breakthrough pain," says Jeffrey H. Buchalter, chief executive officer of Archimedes Pharma. "Lazanda, which uses our patented PecSys® drug delivery system, is designed to deliver medicine in a rapid, but controlled manner, and provides patients with an effective alternative to manage their breakthrough pain."

Breakthrough pain in cancer (BTPc) is an intense, sudden pain that is often unpredictable and debilitating and occurs despite otherwise appropriate opioid therapy for background pain.  BTPc has a different profile from background pain.  BTPc often has high intensity, a rapid onset, usually reaching maximum intensity within five minutes, and a short duration, lasting between 30 and 60 minutes per episode.  On average, BTPc affects more than half of patients with cancer and often interferes with patients' health and ability to engage in daily living activities.

"As the first fentanyl nasal spray in the U.S., Lazanda provides a new approach to managing the often debilitating and inadequately-treated episodes of breakthrough pain that many patients with cancer experience," said Donald Taylor, M.D., director at
'/>"/>

SOURCE Archimedes Pharma Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
2. FDA Approves Nulojix for Kidney Transplant Patients
3. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
4. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
5. FDA Approves Redesigned Labels for Some Merck Drugs
6. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
7. FDA Approves Marketing of RMS Subcutaneous Needle Sets
8. FDA Approves Injectable Gel to Treat Fecal Incontinence
9. FDA approves Incivek for hepatitis C
10. FDA Approves Sutent for Rare Type of Pancreatic Cancer
11. FDA Approves New HIV Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  When Ryan Rendino first felt the ... neck, he figured it was a muscle ... from weight lifting. But the ... A series of doctor appointments followed ... Michel Kliot, MD , a Northwestern ...
(Date:5/21/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that its Board ... the second quarter 2015 of $0.03 per share of ... per share will be paid on June 19, 2015 ... 12, 2015.  The ex-dividend date for the quarterly dividend ...
(Date:5/21/2015)... Mai 2015 Dipexium Pharmaceuticals, ... Unternehmen für Arzneimittel im fortgeschrittenen Entwicklungsstadium, ... Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) und ... wissenschaftliche Posterpräsentation an, welche das innovative ... OneStep-1 und OneStep-2, in der Locilex® ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... a global leader in minimally invasive cryotherapy treatments for ... establishing its new Global Headquarters in Minneapolis, MN. ... in Arden Hills during the fourth quarter of 2009. ... functions, the company will also locate its global marketing, ...
... alternative therapy for Parkinson,s , NEW YORK, Sept. 30 ... Center have reached a milestone in the development of potential ... of current therapy. , The team, which received an MJFF ... LEAPS (Linked Efforts to Accelerate Parkinson,s Solutions) initiative, ...
Cached Medicine Technology:Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN 2Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinson's Disease Hits Major Milestone 2
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the ... of America, Inc. (MTA) has selected IFN as a ... IFN Enterprise Sales Manager, fiber route diversity and network ... transport provides MTA with the diverse fiber transport from ... Internet and voice carriers located at Henry Street in ...
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized ... power learned through meditation and initiation at Special Holistic ... , Yogamaatha, a nine-year-old girl from North Carolina, stunned ... attending the 2015 Business Advocacy Summit at Capitol Hill ... , In a demonstration that lasted three hours, Yogamaatha ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Manufacturers are now ... Performance Factor (HSPF) of 8.2. Experts in the field agree ... benefit consumers. , The HSPF score is what miles per ... more efficient the unit. Although the minimum HSPF score has ... heaters with an HSPF score north of 12. Indeed, the ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 ... technology, communication and capacity are intersecting to create ... across society, the opening speaker at WesternU's 34th ... California Lieut. Gov. Gavin Newsom, a former San ... the keynote speaker at the graduation ceremony for ...
(Date:5/22/2015)... New York (PRWEB) May 22, 2015 ... ) filed on behalf of individuals who allegedly ... to its use continue to move forward in ... According to a Pretrial Order dated May 4, ... preservation of documents and electronically stored information. Among ...
Breaking Medicine News(10 mins):Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4
... finds no connection between the two , , MONDAY, Jan. ... of evidence that rejects the idea that immunizations boost ... incidences of the disorder dropped after makers of most ... products. , Researchers found that autism rates in California ...
... prescriptions for children and adults , , MONDAY, Jan. 7 ... thoughts and behaviors in young people who take antidepressants ... research suggests. , The U.S. Food and Drug Administration ... selective serotonin reuptake inhibitors (SSRIs) might increase the risk ...
... for Emageon presentation, BIRMINGHAM, Ala., Jan. 7 ... in enterprise medical information technology,systems for hospitals, healthcare ... Chairman, CEO and President, will present at the,26th ... January 7-10, 2008,at the Westin St. Francis Hotel ...
... PARK, Calif., Jan. 7 ForSight Labs, LLC announced,today ... VISION3,Inc. with a Series A financing of $6 million, ... the medical technology arena: Morgenthaler,Ventures, Split Rock Partners and ... a significant round of funding to,develop our next innovative ...
... Va., Jan. 7 Specialty Blades, Inc. and ... completed its,acquisition of Popper and Sons, Inc. The ... tubing medical device manufacturing company,makes the combined company ... for the medical device industry. Specialty Blades,originally announced ...
... kept exam dates, study finds , , MONDAY, Jan. 7 ... time in the short-term, people who do so tend not ... Time saved with an Internet purchase may translate into ... that people purchasing lenses from wholesale clubs or optical chains ...
Cached Medicine News:Health News:Study Casts Doubt on Vaccine-Autism Link 2Health News:Study Casts Doubt on Vaccine-Autism Link 3Health News:Youth Suicide Warnings Are Slowing Antidepressant Sales 2Health News:ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding 2Health News:ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding 3Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... The Stryker Cross-Screw System offers ... secure method for ACL reconstruction ... Stryker Cross-Screw System provides the ... The implant comes in Titanium ...
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
Medicine Products: